| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Lupus - A 60 Second Round - Up of the Disease |
|
E-Articles - Lupus - A 60 Second Round - Up of the Disease
The name Lupus means wolf in Latin and because we have known about the disease for the last thousand years or so it is believed it got this name because the skin According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rashes that occur resemble the look of wolf bites. In very broad terms Lupus is a chronic autoimmune disease whereby the immune system, which is designed to atta ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in k abnormal tissue and keep one healthy, becomes hyperactive and attacks normal healthy tissue. At this point in time we do not know what brings on these attacks lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ut they result in inflammation and skin rashes among the visible symptoms. Lupus occurs more frequently in women in that nine out of ten people with lupus are wo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe en. People of all races can have the disease. However, Lupus is also more common in African American women, as well as Hispanic, Asian and Native American femal d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s. There are four different types of Lupus disease and they can be broken down as follows: 1. Cutaneous Lupus erythematosus that affects the skin. 2. Systemi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Lupus erythematosus (SLE) can attack any of the following body systems: skin, joints, lungs, blood, blood vessels, heart, kidneys, liver, brain and the nervous s easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ystem. 3. Drug-induced Lupus may develop after taking certain prescription medicines. However, the symptoms disappear after the drugs are discontinued. 4. Ne nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically natal Lupus is a rare condition. Again, these areas can be broken down into even more detail and, in most cases are treated by your GP or specialist physicians o and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ their advice. Although the disease should be respected and can be deadly, it is considered a manageable chronic disease rather than a fatal one; with 80% to 90% ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi of people living a normal lifespan. Where death does occur, the two most common causes are infection by other opportunist diseases and kidney failure. Lupus is ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ot contagious, nor can it be transmitted through sexual contact; and it isn’t a form of cancer, nor is it in anyway similar to AIDS. In fact, it behaves in the e dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod act opposite way to that of AIDS. The Acquired Immune Deficiency Syndrome has a deficient under active immune system and the immune system in Lupus cases is over cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ctive, producing large quantities of antibodies. Although the cause of Lupus is really unknown, it is believed to be brought on by a number of factors; including tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen one’s genetic make-up and it is suspected that people could inherit it - although there is no scientific proof of this. Exposure to certain unknown factors and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ertain medications can also provide the right environment for this disease to develop. It is also thought extreme stress may also play a part in bringing on Lupu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust , even though there is no scientific evidence of this. Finally, although there is no laid down exercise and diet program for Lupus sufferers one should encourage y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products exercise such as walking, swimming, cycling and other aerobic activities when possible. It is also felt that ‘fats’ play a very important role in the control of . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de his disease and patients should consider a low fat, low sodium, low sugar and high fiber diet similar to those recommended the American Heart or Cancer Bodies. T elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip is brief outline about Lupus should only serve as general background to the disease and if you feel you may be affected in any way, please consult your own doctor tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Houses for Rent in Wayne County, Michigan Dances with Wolves (1990) Deconstructed How to Compare the Major Satellite TV Providers: Dish Network DirecTV
|